Registration
DLA PIPER LLP (US) for REGENXBIO INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to rare disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR New | U.S. Senator |
| KARINA LYNCH New | — |
| MARGARET MARTIN New | Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr |
| MAREN MCBRIDE New | Counsel, Rep. Mollohan |
Medical/Disease Research/Clinical Labs MED
Issues related to rare disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR New | U.S. Senator |
| KARINA LYNCH New | — |
| MARGARET MARTIN New | Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr |
| MAREN MCBRIDE New | Counsel, Rep. Mollohan |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.